Compared with other solid cancers, HCC is considered a chemotherapy-resistant tumor, with excessive expression of dihydropyrimidine dehydrogenase, the P-glycoprotein gene product, and the multidrug resistance gene, MDR-1, so systemic chemotherapy is not routinely used [11,12,13]. The gene discussed is ABCB1; the disease is hepatocellular carcinoma.